Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees

These days, most of our attention has been focused on the COVID-19 pandemic, and we have often neglected what is happening in the environment. For instance, the bacterium re-emerged as a plant pathogen of global importance in 2013 when it was first associated with an olive tree disease epidemic in I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antibiotics (Basel) 2022-07, Vol.11 (7), p.947
Hauptverfasser: Catalano, Alessia, Ceramella, Jessica, Iacopetta, Domenico, Mariconda, Annaluisa, Scali, Elisabetta, Bonomo, Maria Grazia, Saturnino, Carmela, Longo, Pasquale, Aquaro, Stefano, Sinicropi, Maria Stefania
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:These days, most of our attention has been focused on the COVID-19 pandemic, and we have often neglected what is happening in the environment. For instance, the bacterium re-emerged as a plant pathogen of global importance in 2013 when it was first associated with an olive tree disease epidemic in Italy, called Olive Quick Decline Syndrome (OQDS), specifically caused by subspecies ST53, which affects the Salento olive trees (Apulia, South-East Italy). This bacterium, transmitted by the insect is negatively reshaping the Salento landscape and has had a very high impact in the production of olives, leading to an increase of olive oil prices, thus new studies to curb this bacterium are urgently needed. Thidiazuron (TDZ), a diphenylurea ( -phenyl-1,2,3-thiadiazol-5-yl urea), has gained considerable attention in recent decades due to its efficient role in plant cell and tissue culture, being the most suitable growth regulator for rapid and effective plant production in vitro. Its biological activity against bacteria, fungi and biofilms has also been described, and the use of this low-cost compound to fight OQDS may be an intriguing idea.
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics11070947